Options, OTC Updates

Options Reviews:

Despite a poor start to the day. the fresh options ideas we formulated for yesterday morning’s premarket report surged late in the session. The markets caught a momentary respite from the day’s losses leading up to the Fed meeting.

Here were the intraday gains posted by the targets we were tracking as the market spike occurred in the mid-afternoon:

SPY Weekly $321-323 Calls
$321: 1.41-3.50 (+148%)
$321.50: 1.85-3.47 (+88%)
$322: 1.69-2.93 (+73%)
$322.50: 1.51-2.65 (+75%)
$323: 1.33-2.40 (+80%)
_____

AMC Weekly $6-6.50 Calls
$6: .57-.93 (+63%)
$6.50: .35-.60 (+71%)
____

Fresh Ideas:
ADBE $397.50-402.50 Calls
LULU Weekly $315-225 Calls 


OTC Recaps:

Bantek, Inc. BANT  – We had also recently signaled interest in BANT via our extended watchlist on June 1st. We’ve been including a lot more coverage of random OTC plays, and the success with those speculations has continued at a good pace.

Over the eight-session period that we’ve had it in our sights, BANT has traded up from a low of .0031, and went as high as .0085 yesterday. That’s an upswing amounting to 174%
_____

Ethema Health Corp. GRST – We tagged GRST in yesterday morning’s report, and saw a solid double-bag move there as well. The stock traded in a range from .0007-.0017, marking a 143% rip.


Extended Watchlist:
HYSR, PMCB, KBLB, DLCR, KGKG, OMID, HEXO

Blue Horseshoe Stocks: New Highs for OWCP, VDRM & More

OWC Pharmaceutical Research Corp. OWCP – Update

Our readers might have had to do a double-take when we reported our observed range on OWCP leading into yesterday’s session, which was a record-setting 57,956% from the low we saw subsequent to alerting the stock in our premarket report from September 29th (.0036).

We upped the ante even further, stating that “we wouldn’t even be surprised to see our unreal observed range extended even further over coming sessions.”

Sure enough, the stock once again set new highs, trading in a daily range from 2.16 to 3.23 on monstrous volume; good for intraday gains of up to 50% But hold onto your hats, folks, because that new high tabulates to an overall increase of 89,622% in the span of less than four months!

It’s the largest gain of any pick we’ve ever issued, and may hold that record for quite some time, so we just have to give ourselves a huge pat on the back! As to anyone who was along for this ride that had the potential to spawn new millionaires, we salute you as well!


ViaDerma, Inc. VDRM

In terms of alerts that originated in 2017, VDRM is one of our top performers. The stock traded with some excellent price action and volatility yesterday after we included it in our morning report.

There was an early run from .0375 to .065, which works out to an intraday pop of 73% and that was followed by a dip-and-rip from .0376 to a strong close at .0625 (+66%).

Far more impressive is the total amount of ground VDRM has covered since our alert on the stock from January 13th, at which time it was trading at a low of .0048. While it’s peanuts compared to the previously mentioned play, in and of itself, a gain of 1254% in less than six weeks is definitely something special!


Extended Watchlist:
BTX, PPHM, THCT, PURA, KGKG,
CETX(Bottom-Watch)

Blue Horseshoe Stocks: Wrapping Up the Short Week

Before we close out this 3-and-a-half day week, we’d like to take this opportunity to say, we hope everyone enjoyed the Thanksgiving holiday! We’re thankful for having such a great audience of faithful readers! You folks are the reason we get out of bed each day to provide our best insights and ideas on stocks, funds, and options! Cheers to you and yours!


 
Omni Health, Inc. OMHE

We included OMHE as a part of our extended watchlist on Wednesday morning, and the stock followed that up with a respectable performance on the day, despite a very quiet session, as is to be expected just preceding a holiday.

OMHE traded in a range from a low of .026 to a subsequent high of .038, which worked out to an intraday gain of 46% and it came on relatively heavy volume to the tune of nearly six times the monthly average.

Our timing in mentioning this play for the first time ever on Wednesday, was as good as can be, as the stock surged to a new annual high on the day. For these reasons, we’ll be sure to leave this play on our radar in sessions to come.

In an added note, Omni Health is actually a spinoff of a cannabis stock that we have mentioned in the past- MCIG.


Cannabis Roundup

Speaking of cannabis plays, we’ve continued to track the sector on the heels of this month’s elections, as was our intent. On the whole,  activity has been more subdued than expected due to a number of other hot-button areas that have enjoyed good performance, such as the shipping sector boom that we took advantage of a couple of weeks ago.

That being said, we are still as interested as ever in the marijuana space, and many of the plays we’ve been monitoring in that area put up solid numbers just prior to the holiday hiatus, so we just want to provide a quick update on the kind of intraday gains that were made possible:

Medical Marijuana, Inc. MJNA – Range: .083-.115 – Max Gain: 59%

Marijuana Co. of America, Inc. MCOA – Range: .0251-.0575 – Max Gain: 129%

American Cannabis Co. Inc. AMMJ – Range: .461-.8689 – Max Gain: 88%

Vape Holdings, Inc. VAPE – Range: .0058-.0115 – Max Gain: 98%

As always, we’ll remind everyone to keep a general watch over any and all pot plays, as you see the level of opportunity that the sector continues to bring to the table.


Extended Watchlist:
UHLN, LEXG, CRVW, BCCI, BABL, KGKG